PRIMROSE-A: Implementation in Camden 2019-21

Camden CCG, MIND and C&I gained funding from HEE to deliver Primrose-A within a cluster of Camden practices 2019-20. This has continued through Covid.

The adaptation is co-produced with people with lived experience and includes peer coaches to deliver the intervention. It includes a focus on relevant CVD medications and interventions and also recovery goals.

There is a qualitative evaluation element to PRIMROSE-A including an NIHR ARC North Thames multimorbidity theme project which includes qualitative interviews regarding implementation of PRIMROSE A 2020-21.

In November 2020, Camden NHS colleagues and MIND received further HEE funding to roll out the PRIMROSE-A model across North Central London (5 inner London Boroughs)

An adapted version of PRIMROSE is also being trialled in Australia by colleagues in Melbourne: https://www.contemporaryclinicaltrials.com/article/S1551-7144(20)30221-4/fulltext